Dinghua Yang
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 3
- PI3K/AKT/mTOR signaling in cancer 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Huohui Ou (11 shared papers)Yu Huang (10 shared papers)Leyang Xiang (10 shared papers)Haijun Deng (1 shared paper)Jing Li (1 shared paper)Zhiming Liu (1 shared paper)Jiasen Xu (1 shared paper)Shiyang Wu (1 shared paper)
- Journals
- Cancer Science (3 papers)PLoS ONE (2 papers)Digestive Diseases and Sciences (2 papers)Journal of Translational Medicine (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Dinghua Yang
40 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Cancer Research 290
- Oncology 340
- Hepatology 53
- Molecular Biology 418
- Applied Microbiology and Biotechnology 11
Countries citing papers authored by Dinghua Yang
This map shows the geographic impact of Dinghua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinghua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinghua Yang more than expected).
Fields of papers citing papers by Dinghua Yang
This network shows the impact of papers produced by Dinghua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinghua Yang. The network helps show where Dinghua Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dinghua Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 232 | |
| 2 | 2020 | 76 | |
| 3 | 2016 | 67 | |
| 4 | 2017 | 59 | |
| 5 | 2018 | 56 | |
| 6 | 2014 | 52 | |
| 7 | 2015 | 52 | |
| 8 | Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma. | 2015 | 45 |
| 9 | 2016 | 44 | |
| 10 | 2019 | 37 | |
| 11 | 2022 | 32 | |
| 12 | 2017 | 31 | |
| 13 | 2021 | 30 | |
| 14 | 2017 | 26 | |
| 15 | Effect of perioperative fluid therapy on early phase prognosis after liver transplantation. | 2008 | 25 |
| 16 | 2004 | 22 | |
| 17 | Epigenetically silenced linc00261 contributes to the metastasis of hepatocellular carcinoma via inducing the deficiency of FOXA2 transcription. | 2021 | 14 |
| 18 | 2024 | 13 | |
| 19 | 2022 | 12 | |
| 20 | 2003 | 11 |
About Dinghua Yang
Dinghua Yang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cancer Mechanisms and Therapy (4 papers), Epigenetics and DNA Methylation (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), MicroRNA in disease regulation (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (290 citations), Oncology (340 citations), Hepatology (53 citations), Molecular Biology (418 citations) and Applied Microbiology and Biotechnology (11 citations). Dinghua Yang has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Huohui Ou, Yu Huang, Leyang Xiang, Haijun Deng, Jing Li, Zhiming Liu, Jiasen Xu, Shiyang Wu, Ning Yang and Xiaoyu Pu. Their work appears in journals such as Cancer Science, PLoS ONE, Digestive Diseases and Sciences, Journal of Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.